Jun 5, 2026 08:29AM
Jun 5, 2026 08:29AM
Jun 4, 2026 08:31AM
May 29, 2026 08:21AM
May 21, 2026 05:02PM
May 21, 2026 05:02PM
May 15, 2026 08:30AM Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial
May 13, 2026 08:03AM
May 13, 2026 08:00AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 8, 2026 08:45AM
May 8, 2026 08:45AM Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
Apr 23, 2026 08:27AM
Apr 23, 2026 08:25AM
Apr 21, 2026 08:36AM
Apr 7, 2026 12:52PM
Apr 7, 2026 08:42AM
Apr 7, 2026 08:36AM
Apr 7, 2026 08:36AM Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
Mar 23, 2026 08:33AM
Mar 23, 2026 08:31AM
Mar 23, 2026 08:31AM
Mar 19, 2026 08:36AM
Mar 17, 2026 09:05AM
Mar 11, 2026 09:00AM
Mar 11, 2026 09:00AM Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
Feb 19, 2026 08:39AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 18, 2026 08:20AM
Feb 17, 2026 08:35AM
Feb 17, 2026 08:35AM
Feb 13, 2026 08:35AM Moleculin launches CEO Corner platform for investor communication
Feb 13, 2026 08:32AM
Feb 5, 2026 09:15AM
Jan 13, 2026 08:55AM
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM
Jan 12, 2026 08:36AM
Dec 17, 2025 08:31AM Moleculin reports positive Phase 1 results for pediatric brain tumor drug
Dec 17, 2025 08:31AM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:07AM
Dec 8, 2025 08:21AM
Dec 8, 2025 08:21AM Moleculin Announces New Annamycin Collaboration in Brain Tumors
Nov 26, 2025 09:15AM

322,950 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All